Literature DB >> 23667714

Type 2 diabetes in older people; the importance of blood pressure control.

Ankur Jindal1, Adam Whaley-Connell, James R Sowers.   

Abstract

Diabetes and hypertension often coexist and their coexistence substantially promote cardiovascular disease (CVD) and chronic kidney disease. Control of blood pressure to a level of 140/90 mm Hg in people with diabetes can prevent or at least delay CVD and chronic kidney disease.. In the past many society treatment guidelines have stressed tight blood pressure control (=< 130/80) for people with diabetes. But recommendations for such tight blood pressure control have not been supported by recent large randomized control trials, especially in in elderly. Here we review the recent literature regarding the benefits of blood pressure control in elderly patients with diabetics. We further focus on evidence for specific levels of blood pressure treatment goals, in this population subset..

Entities:  

Keywords:  Blood pressure control; Diabetes; Diabetes complications; Hypertension

Year:  2013        PMID: 23667714      PMCID: PMC3647695          DOI: 10.1007/s12170-013-0301-5

Source DB:  PubMed          Journal:  Curr Cardiovasc Risk Rep        ISSN: 1932-9520


  26 in total

1.  Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.

Authors:  Toshiharu Ninomiya; Sophia Zoungas; Bruce Neal; Mark Woodward; Anushka Patel; Vlado Perkovic; Alan Cass; Mark Cooper; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Lisheng Liu; Giuseppe Mancia; Carl-Erik Mogensen; Neil Poulter; Anthony Rodgers; Bryan Williams; Stephen MacMahon; John Chalmers
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

2.  Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes.

Authors:  John B Kostis; Alan C Wilson; Ronald S Freudenberger; Nora M Cosgrove; Sara L Pressel; Barry R Davis
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

3.  Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-Plus Study.

Authors:  Thomas van Bemmel; Karen Woittiez; Gerard J Blauw; Femke van der Sman-de Beer; Friedo W Dekker; Rudi G J Westendorp; Jacobijn Gussekloo
Journal:  J Am Soc Nephrol       Date:  2006-08-16       Impact factor: 10.121

4.  Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial.

Authors:  N Beckett; R Peters; J Tuomilehto; C Swift; P Sever; J Potter; T McCormack; F Forette; B Gil-Extremera; D Dumitrascu; J A Staessen; L Thijs; A Fletcher; C Bulpitt
Journal:  BMJ       Date:  2011-01-04

5.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

6.  Association between blood pressure and survival over 9 years in a general population aged 85 and older.

Authors:  Sari Rastas; Tuula Pirttilä; Petteri Viramo; Auli Verkkoniemi; Pirjo Halonen; Kati Juva; Leena Niinistö; Kimmo Mattila; Esko Länsimies; Raimo Sulkava
Journal:  J Am Geriatr Soc       Date:  2006-06       Impact factor: 5.562

7.  Cerebral microvascular disease predicts renal failure in type 2 diabetes.

Authors:  Takashi Uzu; Yasuo Kida; Nobuo Shirahashi; Tamaki Harada; Atsushi Yamauchi; Makoto Nomura; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugimoto; Daisuke Koya; Masakazu Haneda; Atsunori Kashiwagi; Ryuichi Kikkawa
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

8.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

9.  Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control.

Authors:  Ming-Chia Hsieh; Yi-Ting Hsieh; Tzu-Jung Cho; Jung-Fu Chen; Shi-Dou Lin; Hung-Chun Chen; Shih-Te Tu
Journal:  Eur J Clin Invest       Date:  2011-02-08       Impact factor: 4.686

10.  Lowering blood pressure reduces renal events in type 2 diabetes.

Authors:  Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

View more
  3 in total

1.  Poor blood pressure control and its associated factors among older people with hypertension: A cross-sectional study in six public primary care clinics in Malaysia.

Authors:  A T Cheong; S G Sazlina; S F Tong; A S Azah; S Salmiah
Journal:  Malays Fam Physician       Date:  2015-04-30

Review 2.  Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Authors:  Ankur Jindal; Mariana Garcia-Touza; Nidhi Jindal; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-08-01       Impact factor: 4.741

3.  Potential therapeutic effects of endothelial cells trans-differentiated from Wharton's Jelly-derived mesenchymal stem cells on altered vascular functions in aged diabetic rat model.

Authors:  Shaimaa M Motawea; Rasha I Noreldin; Yahya M Naguib
Journal:  Diabetol Metab Syndr       Date:  2020-05-11       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.